The dopamine (DA) projections from the ventral tegmental area to the nucleus accumbens (NAc) are the key component of the brain reward circuitry. The encoded information by DA in reward-related memory within this circuit during opiate reinforcement requires further clarification. The present study was designed to explore the correlations between morphine dose, retention of morphine-induced conditioned place preference (CPP), morphine-induced changes in levels of DA and its metabolites in the NAc in expression and retention of CPP in Sprague-Dawley male rats. A dose-effect curve for morphine-induced CPP (0.01-10 mg/kg, i.p.) was obtained using 4-day conditioning sessions followed by a CPP test; the retention of morphine CPP was measured with...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
Increasing evidence suggests that in addition to the mesoaccumbens dopamine (DA) system other neurot...
Positive motivational properties of opioids, stimulants and serotonin selective reuptake inhibitors ...
Our previous study demonstrated that morphine dose- and time-dependently elevated dopamine (DA) conc...
Our previous study demonstrated that morphine dose- and time-dependently elevated dopamine (DA) conc...
Our previous study demonstrated that morphine dose- and time-dependently elevated dopamine (DA) conc...
RATIONALE: A large body of evidence indicates an involvement of the mesolimbic dopamine (DA) pathway...
RATIONALE: A large body of evidence indicates an involvement of the mesolimbic dopamine (DA) pathway...
In the previous study we reported that morphine-induced conditioned place preference (CPP) could be ...
The present study used the conditioned place preference (CPP) paradigm to examine the neural mechani...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
Background: Some investigators indicated the effect of electrical or chemical stimulation on differe...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
Increasing evidence suggests that in addition to the mesoaccumbens dopamine (DA) system other neurot...
Positive motivational properties of opioids, stimulants and serotonin selective reuptake inhibitors ...
Our previous study demonstrated that morphine dose- and time-dependently elevated dopamine (DA) conc...
Our previous study demonstrated that morphine dose- and time-dependently elevated dopamine (DA) conc...
Our previous study demonstrated that morphine dose- and time-dependently elevated dopamine (DA) conc...
RATIONALE: A large body of evidence indicates an involvement of the mesolimbic dopamine (DA) pathway...
RATIONALE: A large body of evidence indicates an involvement of the mesolimbic dopamine (DA) pathway...
In the previous study we reported that morphine-induced conditioned place preference (CPP) could be ...
The present study used the conditioned place preference (CPP) paradigm to examine the neural mechani...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
Background: Some investigators indicated the effect of electrical or chemical stimulation on differe...
In opioid addiction, cues and contexts associated with drug reward can be powerful triggers for drug...
Increasing evidence suggests that in addition to the mesoaccumbens dopamine (DA) system other neurot...
Positive motivational properties of opioids, stimulants and serotonin selective reuptake inhibitors ...